StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30956% above fair value
$55.39+1.28 (+2.37%)

Close on Nov 20, 2026Market cap $2.82BP/E 263.8Yield –

AtriCure free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

AtriCure's free cash flow for the twelve months ending Jun 30, 2026 was $53.11M, up 110.0% year over year. For fiscal 2025 it was $48.28M, up 6381.1% from the year before. The highest annual figure on record is $48.28M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.28M+6381.1%
FY2024Dec 31, 2024$745.00K–
FY2023Dec 31, 2023-$7.51M–
FY2022Dec 31, 2022-$39.02M–
FY2021Dec 31, 2021-$23.53M–
FY2020Dec 31, 2020-$25.13M–
FY2019Dec 31, 2019-$27.99M–
FY2018Dec 31, 2018-$10.38M–
FY2017Dec 31, 2017-$15.33M–
FY2016Dec 31, 2016-$22.81M–
FY2015Dec 31, 2015-$21.29M–
FY2014Dec 31, 2014-$27.11M–
FY2013Dec 31, 2013-$8.09M–
FY2012Dec 31, 2012-$4.92M–
FY2011Dec 31, 2011-$3.51M–
FY2010Dec 31, 2010-$1.85M–
FY2009Dec 31, 2009-$940.51K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.43M-2.8%
Q1 FY2026Mar 31, 2026-$7.85M–
Q4 FY2025Dec 31, 2025$18.43M+486.2%
Q3 FY2025Sep 30, 2025$24.11M+47.1%
Q2 FY2025Jun 30, 2025$18.96M+279.4%
Q1 FY2025Mar 31, 2025-$13.21M–
Q4 FY2024Dec 31, 2024$3.14M+152.7%
Q3 FY2024Sep 30, 2024$16.40M–
Q2 FY2024Jun 30, 2024$5.00M–
Q1 FY2024Mar 31, 2024-$23.79M–
Q4 FY2023Dec 31, 2023$1.24M–
Q3 FY2023Sep 30, 2023-$2.11M–
Q2 FY2023Jun 30, 2023-$69.00K-253.3%
Q1 FY2023Mar 31, 2023-$6.58M–
Q4 FY2022Dec 31, 2022-$4.13M–
Q3 FY2022Sep 30, 2022-$6.93M–
Q2 FY2022Jun 30, 2022$45.00K–
Q1 FY2022Mar 31, 2022-$28.01M–
Q4 FY2021Dec 31, 2021-$2.41M-183.0%
Q3 FY2021Sep 30, 2021-$1.74M-168.1%
Q2 FY2021Jun 30, 2021-$8.75M–
Q1 FY2021Mar 31, 2021-$10.64M–
Q4 FY2020Dec 31, 2020$2.90M–
Q3 FY2020Sep 30, 2020$2.55M–
Q2 FY2020Jun 30, 2020-$12.66M-1367.3%
Q1 FY2020Mar 31, 2020-$17.92M–
Q4 FY2019Dec 31, 2019-$7.89M–
Q3 FY2019Sep 30, 2019-$5.96M-267.5%
Q2 FY2019Jun 30, 2019$999.00K–
Q1 FY2019Mar 31, 2019-$15.15M–
Q4 FY2018Dec 31, 2018-$98.00K-135.1%
Q3 FY2018Sep 30, 2018$3.56M–
Q2 FY2018Jun 30, 2018-$2.32M–
Q1 FY2018Mar 31, 2018-$11.52M–
Q4 FY2017Dec 31, 2017$279.00K–
Q3 FY2017Sep 30, 2017-$1.52M–
Q2 FY2017Jun 30, 2017-$2.82M–
Q1 FY2017Mar 31, 2017-$11.27M–
Q4 FY2016Dec 31, 2016-$829.00K–
Q3 FY2016Sep 30, 2016-$685.00K–

More AtriCure figures

See a number that looks wrong?